Zymergen Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 763
Employees
  • Stock Symbol
  • ZY
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $3.21
  • (As of Monday Closing)

Zymergen General Information

Description

Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Contact Information

Website
www.zymergen.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Materials
Other Commercial Products
Stock Exchange
NAS
Primary Office
  • 5980 Horton Street
  • Suite 105
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Zymergen Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymergen Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.21 $3.23 $3.08 - $52.00 $331M 102M 1.04M -$5.16

Zymergen Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2015 31-Dec-2015
EV 850,654
Revenue 19,610 13,284 15,419 10,000
EBITDA (328,710) (233,068) (223,574)
Net Income (359,245) (262,194) (236,803)
Total Assets 627,336 304,921 227,890
Total Debt 80,221 79,331 78,310
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zymergen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based break
Biotechnology
Emeryville, CA
763 As of 2021
00.000
0.000 0000-00-00
00000000 00.000

000000

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
0000000000000
Seattle, WA
00 As of 0000
000.00
0000000000 0 000.00

0000000

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
Roslin, United Kingdom
0 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zymergen Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 Corporation Roslin, United Kingdom 0 0000000000
000000 00000000 00 Formerly VC-backed Boston, MA 000 00.000 000000000 00.000
00000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Berkeley, CA 00 0000 00000000000 0000
To view Zymergen’s complete competitors history, request access »

Zymergen Patents

  • 22

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Zymergen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190046916-A1 Metal-organic framework materials Pending 17-Jul-2017 000000000
CA-3049989-A1 A modular universal plasmid design strategy for the assembly and editing of multiple dna constructs for multiple hosts Pending 10-Feb-2017 000000000
CA-3048658-A1 A method to build fungal production strains using automated steps for genetic manipulation and strain purification Pending 30-Dec-2016 000000000
EP-3562945-A1 A method to build fungal production strains using automated steps for genetic manipulation and strain purification Pending 30-Dec-2016 000000000
JP-2020503037-A Methods for constructing fungal producers using automated steps for genetic manipulation and strain purification Pending 30-Dec-2016 C12N15/87
To view Zymergen’s complete patent history, request access »

Zymergen Executive Team (20)

Name Title Board Seat Contact Info
Jay Flatley Chief Executive Officer & Chairman
Richard Pieters President
Enakshi Singh Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Aaron Kimball Chief Technology Officer, Technology
Subodh Deshmukh Chief Development Officer
You’re viewing 5 of 20 executive team members. Get the full list »

Zymergen Board Members (10)

Name Representing Role Since
Christine Gorjanc Zymergen Board Member 000 0000
Dipchand Nishar SoftBank Group Board Member 000 0000
Jay Flatley Zymergen Chief Executive Officer & Chairman 000 0000
Matthew Ocko DCVC Board Member 000 0000
Rohit Sharma Ph.D True Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Zymergen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymergen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 16-May-2021 0000000000 000.00 Drug Discovery
0000000 19-Mar-2020 0000000000 000.00 Biotechnology 000000 00
Radiant Genomics 08-Jan-2018 Merger/Acquisition Other Commercial Services 000000 00
To view Zymergen’s complete acquisitions history, request access »

Zymergen Subsidiaries (2)

Company Name Industry Location Founded
Radiant Genomics Other Commercial Services Emeryville, CA 2012
0000000 Biotechnology Medford, MA 0000
To view Zymergen’s complete subsidiaries history, request access »